Health-related quality of life (HRQoL) in MONARCH 2: Abemaciclib plus fulvestrant in women with HR+, HER2-advanced breast cancer (ABC) who progressed on endocrine therapy Kaufman, P. A., Toi, M., Neven, P., Sohn, J., Price, G. L., Lin, Y., Boye, M., Li, L., Gable, J., Carter, G., Sledge, G. W. AMER SOC CLINICAL ONCOLOGY. 2018

View details for DOI 10.1200/JCO.2018.36.15_suppl.1049

View details for Web of Science ID 000442916001071